The KBMA P. aeruginosa vaccine activates human moDCs and induces
antigen-specific CD8+
T-cell responses in vitro. (a) Expression of the maturation
markers (CD80, CD86, CD83, and CD40) on the surface of human moDCs infected with live or
KBMA strains, at MOI 100:1. (a,b) Not treated lipopolysaccharide (LPS) and
CD40L were used as controls. (b) Cytokine secretion by human moDCs following
live-strain and KBMA stimulation (n = 5); (c,d)
Cross-presentation of flu M1 epitope by DCs submitted to OSTAB or KBMA strains assayed
by intracellular IFN-γ labeling within tetramer flu-specific CD8+ T cells from
cocultures. T2 and mDC loaded with the epitope were used as controls. (c) One
representative experiment, (d) mean of four experiments. (e)
Cross-presentation of flu M1 epitope by DCs submitted to OSTAB or KBMA strains assayed
by IFN-γ measurement in the supernatants of the cultures (n = 5–8
experiments). HK, heat-killed; KBMA, “killed but metabolically active” MOI,
multiplicity of infection.